ATE350036T1 - Tetrahydroquinolin-derivate - Google Patents
Tetrahydroquinolin-derivateInfo
- Publication number
- ATE350036T1 ATE350036T1 AT00964738T AT00964738T ATE350036T1 AT E350036 T1 ATE350036 T1 AT E350036T1 AT 00964738 T AT00964738 T AT 00964738T AT 00964738 T AT00964738 T AT 00964738T AT E350036 T1 ATE350036 T1 AT E350036T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydroquinoline derivatives
- derivatives
- salts
- tetrahydroquinoline
- agonism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29202199 | 1999-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE350036T1 true ATE350036T1 (de) | 2007-01-15 |
Family
ID=17776517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00964738T ATE350036T1 (de) | 1999-10-14 | 2000-10-06 | Tetrahydroquinolin-derivate |
Country Status (10)
Country | Link |
---|---|
US (1) | US7037919B1 (de) |
EP (1) | EP1221439B1 (de) |
KR (2) | KR100826485B1 (de) |
CN (1) | CN1157379C (de) |
AT (1) | ATE350036T1 (de) |
AU (1) | AU7558900A (de) |
CA (1) | CA2387201C (de) |
DE (1) | DE60032780T2 (de) |
ES (1) | ES2277853T3 (de) |
WO (1) | WO2001027086A1 (de) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7855229B2 (en) | 2000-08-24 | 2010-12-21 | University Of Tennessee Research Foundation | Treating wasting disorders with selective androgen receptor modulators |
US7622503B2 (en) | 2000-08-24 | 2009-11-24 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US7645898B2 (en) | 2000-08-24 | 2010-01-12 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and method of use thereof |
US7919647B2 (en) | 2000-08-24 | 2011-04-05 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US8853266B2 (en) | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
US7772433B2 (en) | 2002-02-28 | 2010-08-10 | University Of Tennessee Research Foundation | SARMS and method of use thereof |
EP1520856A4 (de) * | 2002-06-19 | 2010-01-13 | Kaken Pharma Co Ltd | Androgenrezeptorantagonist |
JPWO2004013104A1 (ja) * | 2002-08-01 | 2006-09-21 | 科研製薬株式会社 | 新規テトラヒドロキノリン誘導体 |
US7504508B2 (en) | 2002-10-04 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
AU2003277285B2 (en) | 2002-10-04 | 2007-12-13 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US7011600B2 (en) | 2003-02-28 | 2006-03-14 | Fallbrook Technologies Inc. | Continuously variable transmission |
MXPA06001751A (es) | 2003-08-22 | 2006-05-12 | Ligand Pharm Inc | Derivados de 6-cicloamino-2-quinolinona como compuestos moduladores de receptor de androgeno. |
WO2005063735A1 (de) * | 2003-12-20 | 2005-07-14 | Merck Patent Gmbh | 2- (hetero) -arylsubstituierte tetrahydrochinolinderivate |
SE0400285D0 (sv) * | 2004-02-10 | 2004-02-10 | Astrazeneca Ab | Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof |
WO2005090282A1 (en) | 2004-03-12 | 2005-09-29 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
WO2005097127A2 (en) | 2004-04-02 | 2005-10-20 | Merck & Co., Inc. | Method of treating men with metabolic and anthropometric disorders |
US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
KR20070114762A (ko) | 2005-02-24 | 2007-12-04 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 염증 질환 치료를 위한 pgd2 수용체 길항제 |
KR101293935B1 (ko) | 2005-06-17 | 2013-08-08 | 리간드 파마슈티칼스 인코포레이티드 | 안드로겐 수용체 조절 화합물 및 방법 |
KR101831822B1 (ko) | 2005-10-28 | 2018-02-23 | 폴브룩 인텔렉츄얼 프로퍼티 컴퍼니 엘엘씨 | 전동 드라이브 |
PL1954959T3 (pl) | 2005-11-22 | 2013-10-31 | Fallbrook Ip Co Llc | Przekładnia bezstopniowa |
CN100376582C (zh) * | 2006-04-26 | 2008-03-26 | 浙江大学 | 一种六氢呋喃[3,2-c]喹啉衍生物的制备方法 |
US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
UA98777C2 (en) * | 2006-11-20 | 2012-06-25 | Эли Лилли Энд Компани | Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators |
EP2125469A2 (de) | 2007-02-01 | 2009-12-02 | Fallbrook Technologies Inc. | System und verfahren zur getriebe- und/oder antriebsmotorsteuerung |
TWI461615B (zh) | 2007-02-16 | 2014-11-21 | Fallbrook Ip Co Llc | 無限可變變速器、連續可變變速器、方法、組件、次組件以及其零件 |
EP2573425A3 (de) | 2007-04-24 | 2017-07-26 | Fallbrook Intellectual Property Company LLC | Elektrische Fahrantriebe |
US7968603B2 (en) | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
CA2708634C (en) | 2007-12-21 | 2017-08-01 | Fallbrook Technologies Inc. | Automatic transmissions and methods therefor |
CA2942806C (en) | 2008-02-29 | 2018-10-23 | Fallbrook Intellectual Property Company Llc | Continuously and/or infinitely variable transmissions and methods therefor |
WO2009132307A1 (en) * | 2008-04-24 | 2009-10-29 | The Regents Of The University Of California | Small-molecule inhibitors of the androgen receptor |
CN107246463A (zh) | 2008-06-23 | 2017-10-13 | 福博科知识产权有限责任公司 | 无级变速器 |
CA2732668C (en) | 2008-08-05 | 2017-11-14 | Fallbrook Technologies Inc. | Methods for control of transmission and prime mover |
US8167759B2 (en) | 2008-10-14 | 2012-05-01 | Fallbrook Technologies Inc. | Continuously variable transmission |
PL2419658T3 (pl) | 2009-04-16 | 2014-02-28 | Fallbrook Ip Co Llc | Zespół stojana i mechanizm zmiany biegów do bezstopniowej skrzyni biegów |
US8512195B2 (en) | 2010-03-03 | 2013-08-20 | Fallbrook Intellectual Property Company Llc | Infinitely variable transmissions, continuously variable transmissions, methods, assemblies, subassemblies, and components therefor |
US8888643B2 (en) | 2010-11-10 | 2014-11-18 | Fallbrook Intellectual Property Company Llc | Continuously variable transmission |
CN103763924B (zh) * | 2011-06-17 | 2016-05-18 | 默沙东公司 | 作为crth2受体调节剂的环烷基稠合的四氢喹啉 |
CN108143728A (zh) | 2012-07-13 | 2018-06-12 | Gtx公司 | 选择性雄激素受体调节剂在治疗乳癌中的用途 |
US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
CN105017266B (zh) * | 2015-07-17 | 2017-07-18 | 安徽农业大学 | 手性2‑芳基‑1,2,3,4‑四氢喹啉类化合物及其合成方法 |
JP2022532342A (ja) | 2019-05-14 | 2022-07-14 | ニューベイション・バイオ・インコーポレイテッド | 抗がん核内ホルモン受容体標的化化合物 |
WO2021097046A1 (en) | 2019-11-13 | 2021-05-20 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
CN116096367A (zh) * | 2020-06-08 | 2023-05-09 | 苏黎世大学 | Frs2–fgfr相互作用的小分子抑制剂及其在医学、在预防和治疗癌症中的用途 |
IL306010A (en) | 2021-03-23 | 2023-11-01 | Nuvation Bio Inc | Anticancer compounds against the nuclear hormone receptor |
CN117580839A (zh) | 2021-05-03 | 2024-02-20 | 诺维逊生物股份有限公司 | 抗癌核激素受体靶向化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2500441A1 (fr) * | 1981-02-23 | 1982-08-27 | Roussel Uclaf | Nouveaux medicaments derives de la 3-hydroxy dodecahydro benz (e) inden-7-one, produits derives de la 3-hydroxy dodecahydro benz (e) inden-7-one et leur procede de preparation |
US5288725A (en) * | 1992-10-15 | 1994-02-22 | Merck & Co., Inc. | Pyrroloquinoline Bradykinin antagonist |
DE69531998T2 (de) * | 1994-12-22 | 2004-07-22 | Ligand Pharmaceuticals, Inc., San Diego | Steroidrezeptor-modulator verbindungen und methoden |
US5925527A (en) | 1997-02-04 | 1999-07-20 | Trega Biosciences, Inc. | Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries |
-
2000
- 2000-10-06 WO PCT/JP2000/007007 patent/WO2001027086A1/ja active IP Right Grant
- 2000-10-06 KR KR1020077004896A patent/KR100826485B1/ko not_active IP Right Cessation
- 2000-10-06 DE DE60032780T patent/DE60032780T2/de not_active Expired - Fee Related
- 2000-10-06 AT AT00964738T patent/ATE350036T1/de not_active IP Right Cessation
- 2000-10-06 US US10/110,636 patent/US7037919B1/en not_active Expired - Fee Related
- 2000-10-06 KR KR1020027004708A patent/KR100731566B1/ko not_active IP Right Cessation
- 2000-10-06 EP EP00964738A patent/EP1221439B1/de not_active Expired - Lifetime
- 2000-10-06 CN CNB008141835A patent/CN1157379C/zh not_active Expired - Fee Related
- 2000-10-06 ES ES00964738T patent/ES2277853T3/es not_active Expired - Lifetime
- 2000-10-06 CA CA002387201A patent/CA2387201C/en not_active Expired - Fee Related
- 2000-10-06 AU AU75589/00A patent/AU7558900A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60032780T2 (de) | 2007-11-08 |
KR100731566B1 (ko) | 2007-06-22 |
DE60032780D1 (de) | 2007-02-15 |
CA2387201A1 (en) | 2001-04-19 |
EP1221439A4 (de) | 2003-01-15 |
WO2001027086A1 (fr) | 2001-04-19 |
CA2387201C (en) | 2009-05-26 |
KR100826485B1 (ko) | 2008-05-02 |
CN1378535A (zh) | 2002-11-06 |
ES2277853T3 (es) | 2007-08-01 |
US7037919B1 (en) | 2006-05-02 |
CN1157379C (zh) | 2004-07-14 |
EP1221439A1 (de) | 2002-07-10 |
KR20070036192A (ko) | 2007-04-02 |
EP1221439B1 (de) | 2007-01-03 |
KR20020056901A (ko) | 2002-07-10 |
AU7558900A (en) | 2001-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60032780D1 (de) | Tetrahydroquinolin-derivate | |
WO2002100860A3 (fr) | Composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens | |
DK0778277T3 (da) | Substituerede heterocycliske derivater som CRF antagonister | |
ES2182234T3 (es) | Inhibidores de metaloproteasa. | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
PT911333E (pt) | Derivados de pirazolo¬4,3-d|pirimidina e composicoes farmaceuticas que os contenham | |
IL159418A0 (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
MY136141A (en) | Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors | |
RS49673B (sr) | Inhibitori sintaze azot-monoksida | |
ES2172864T3 (es) | 2-metoxibenzofenonas fungicidas. | |
FI902555A0 (fi) | Diarylstyrylkinolindisyror. | |
ATE377602T1 (de) | Morphinanderivate und ihre medizinische anwendung | |
ATE278661T1 (de) | Anthranilsäurederivate | |
BR0109542A (pt) | Derivados de imidazopirina alquilados | |
ES2166046T3 (es) | Derivados de arilacrilamida como agonistas o antagonistas de 5ht1. | |
BR0209901A (pt) | Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina | |
BR9902084A (pt) | Heterociclos. | |
FI952420A (fi) | Glukopyranosidibentsotiofeenit | |
CA2423357A1 (en) | Fused heterocyclic derivatives as phosphodiesterase inhibitors | |
BR0207966A (pt) | Composição farmacêutica contendo derivados 1,3-tiazina | |
BR9902096A (pt) | Pitazóis. | |
FI20000421A0 (fi) | Nukleotidejä sisältävien yhdisteiden kuljetukseen käyttökelpoisia 1,4-Dihydropyridiinijohdannaisia | |
IL160162A0 (en) | Salts of substituted 1,2,3,4,-tetrahydroisoquinolie-2-carboxylic acid derivatives | |
EP1118327A4 (de) | Vorbeugende und/oder therapeutische mittel zur behandlung der sinusitis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |